DK115144B - Process for the preparation of antitussive complexes of opium alkaloids. - Google Patents

Process for the preparation of antitussive complexes of opium alkaloids.

Info

Publication number
DK115144B
DK115144B DK142867AA DK142867A DK115144B DK 115144 B DK115144 B DK 115144B DK 142867A A DK142867A A DK 142867AA DK 142867 A DK142867 A DK 142867A DK 115144 B DK115144 B DK 115144B
Authority
DK
Denmark
Prior art keywords
antitussive
complexes
preparation
opium alkaloids
opium
Prior art date
Application number
DK142867AA
Other languages
Danish (da)
Inventor
A Weber
C Mony
Original Assignee
Mead Johnson & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson & Co filed Critical Mead Johnson & Co
Publication of DK115144B publication Critical patent/DK115144B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C08B37/0042—Carragenan or carragen, i.e. D-galactose and 3,6-anhydro-D-galactose, both partially sulfated, e.g. from red algae Chondrus crispus or Gigantia stellata; kappa-Carragenan; iota-Carragenan; lambda-Carragenan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK142867AA 1966-03-18 1967-03-17 Process for the preparation of antitussive complexes of opium alkaloids. DK115144B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR54024A FR5227M (en) 1966-03-18 1966-03-18

Publications (1)

Publication Number Publication Date
DK115144B true DK115144B (en) 1969-09-08

Family

ID=8604122

Family Applications (1)

Application Number Title Priority Date Filing Date
DK142867AA DK115144B (en) 1966-03-18 1967-03-17 Process for the preparation of antitussive complexes of opium alkaloids.

Country Status (6)

Country Link
AT (1) AT279802B (en)
BE (1) BE695604A (en)
DK (1) DK115144B (en)
FR (1) FR5227M (en)
GB (1) GB1183403A (en)
NL (1) NL6704037A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171716B1 (en) * 1982-03-12 1997-04-07 Pharmacia & Upjohn Ab Process for the preparation of a complex of carrageenan and emepronium, doxycycline or propranolol
AU565487B2 (en) * 1983-09-16 1987-09-17 Fisons Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents
US4762709A (en) * 1983-09-16 1988-08-09 Pennwalt Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents
US4898860A (en) * 1985-08-16 1990-02-06 New York University Anticonvulsant composition and method
US4694010A (en) * 1985-08-16 1987-09-15 New York University Anticonvulsant compositions and method
FR2640137A1 (en) * 1988-12-08 1990-06-15 Texinfine Sa SYSTEMS CONVEYING LIPOPHILIC ACTIVE INGREDIENTS AND PROCESS FOR OBTAINING SAME
DK0454044T3 (en) * 1990-04-25 1996-04-22 Hoechst Ag Pharmacological preparation containing polyelectrolyte complexes in microparticle form and at least one active substance
IT1297461B1 (en) 1997-10-29 1999-12-17 Ciocca Maurizio PREPARATION OF CONTROLLED RELEASE TABLETS BASED ON COMPLEXES BETWEEN CARRAGENANO AND SOLUBLE BASIC DRUGS
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
DE102004013637A1 (en) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Process for the preparation of CS particles and microcapsules using porous templates as well as CS particles and microcapsules
FR2906687A1 (en) * 2006-10-10 2008-04-11 Pierre Calleja Substrate for conservation and distribution of an active ingredient for aquatic animals, comprises an active ingredient, a hydrocolloid substance to inflate in contact with water, a palatable base, and a compressed metal base

Also Published As

Publication number Publication date
GB1183403A (en) 1970-03-04
BE695604A (en) 1967-09-18
NL6704037A (en) 1967-09-19
AT279802B (en) 1970-03-25
FR5227M (en) 1967-08-14

Similar Documents

Publication Publication Date Title
DK123598B (en) Analogous process for the preparation of tetrahydroisoquinolines.
DK115144B (en) Process for the preparation of antitussive complexes of opium alkaloids.
DK123482B (en) Analogous process for the preparation of alkaloids.
DK117706B (en) Process for the preparation of pyrrole derivatives.
DK114697B (en) Process for the preparation of 25-desacetyl derivatives of rifamycins.
DK129941B (en) Process for the preparation of tricyclohexyltin hydroxide.
DK117954B (en) Process for the preparation of 3-amino-2-cyanoacrylamide.
DK124886B (en) Process for the preparation of 1-hydroxy-benzimidazole-N-oxides.
DK136982B (en) Process for the preparation of quinoline derivatives.
DK115551B (en) Process for the preparation of 6-aminouracil-5-carbonamide-N-sulfonamides.
DK114063B (en) Process for the preparation of 1-methyl-2-isopropyl-5-nitro-imidazole.
DK120344B (en) Process for the preparation of 5-benzyl-pyrimidines.
DK122761B (en) Analogous process for the preparation of arylsulfonylurea derivatives.
DK120132B (en) Analogous process for the preparation of quinoline derivatives.
DK117704B (en) Analogous process for the preparation of tetrahydroisoquinoline derivatives.
DK117703B (en) Analogous process for the preparation of anticoccidially active quinoline derivatives.
DK114270B (en) Process for the preparation of benzazole derivatives.
DK121706B (en) Process for the preparation of monothioether glycol.
DK114626B (en) Process for the preparation of 2-substituted-4-amino-5-acylamidomethylpyrimidine.
FI45952C (en) Process for the preparation of formaldehyde.
DK117232B (en) Process for the preparation of α-aminoacylated esters of vinca alkaloids.
DK113715B (en) Analogous process for the preparation of theophylline derivatives.
DK120239B (en) Process for the preparation of piperazine-phenylethanol derivatives.
DK117071B (en) Process for the preparation of 7- [β-hydroxy-γ- (methyl-β-hydroxyethylamino) -propyl] -theophylline nicotinate.
DK113292B (en) Process for the preparation of azabicycloalkanes.